677 related articles for article (PubMed ID: 29307188)
21. Melt Crystallization of Indomethacin Polymorphs in the Presence of Poly(ethylene oxide): Selective Enrichment of the Polymer at the Crystal-Liquid Interface.
Zhang J; Shi Q; Guo M; Liu Z; Cai T
Mol Pharm; 2020 Jun; 17(6):2064-2071. PubMed ID: 32298128
[TBL] [Abstract][Full Text] [Related]
22. Physicochemical characterization of solid dispersions of indomethacin with PEG 6000, Myrj 52, lactose, sorbitol, dextrin, and Eudragit E100.
Valizadeh H; Nokhodchi A; Qarakhani N; Zakeri-Milani P; Azarmi S; Hassanzadeh D; Löbenberg R
Drug Dev Ind Pharm; 2004 Mar; 30(3):303-17. PubMed ID: 15109030
[TBL] [Abstract][Full Text] [Related]
23. Preparation and characterization of spironolactone-loaded gelucire microparticles using spray-drying technique.
Yassin AE; Alanazi FK; El-Badry M; Alsarra IA; Barakat NS; Alanazi FK
Drug Dev Ind Pharm; 2009 Mar; 35(3):297-304. PubMed ID: 18821154
[TBL] [Abstract][Full Text] [Related]
24. Impact of Polymer Enrichment at the Crystal-Liquid Interface on Crystallization Kinetics of Amorphous Solid Dispersions.
Zhang J; Shi Q; Tao J; Peng Y; Cai T
Mol Pharm; 2019 Mar; 16(3):1385-1396. PubMed ID: 30716277
[TBL] [Abstract][Full Text] [Related]
25. Effect of preparation method on the surface properties and UV imaging of indomethacin solid dispersions.
Asare-Addo K; Alshafiee M; Walton K; Ward A; Totea AM; Taheri S; Mawla N; Adebisi AO; Elawad S; Diza C; Timmins P; Conway BR
Eur J Pharm Biopharm; 2019 Apr; 137():148-163. PubMed ID: 30836178
[TBL] [Abstract][Full Text] [Related]
26. Phase characterization of indomethacin in adsorbates onto hydroxyethylcellulose.
Bogdanova S; Bontcheva E; Avramova N
Drug Dev Ind Pharm; 2007 Aug; 33(8):900-6. PubMed ID: 17729108
[TBL] [Abstract][Full Text] [Related]
27. Enhanced kinetic solubility profiles of indomethacin amorphous solid dispersions in poly(2-hydroxyethyl methacrylate) hydrogels.
Sun DD; Ju TC; Lee PI
Eur J Pharm Biopharm; 2012 May; 81(1):149-58. PubMed ID: 22233548
[TBL] [Abstract][Full Text] [Related]
28. Preparation and physicochemical characterizations of tanshinone IIA solid dispersion.
Zhao X; Liu X; Gan L; Zhou C; Mo J
Arch Pharm Res; 2011 Jun; 34(6):949-59. PubMed ID: 21725816
[TBL] [Abstract][Full Text] [Related]
29. Free flowing solid dispersions of the anti-HIV drug UC 781 with Poloxamer 407 and a maximum amount of TPGS 1000: investigating the relationship between physicochemical characteristics and dissolution behaviour.
Goddeeris C; Van den Mooter G
Eur J Pharm Sci; 2008 Sep; 35(1-2):104-13. PubMed ID: 18644442
[TBL] [Abstract][Full Text] [Related]
30. Crystallization of bifonazole and acetaminophen within the matrix of semicrystalline, PEO-PPO-PEO triblock copolymers.
Chen Z; Liu Z; Qian F
Mol Pharm; 2015 Feb; 12(2):590-9. PubMed ID: 25569586
[TBL] [Abstract][Full Text] [Related]
31. Preparation and characterization of gliclazide-polyethylene glycol 4000 solid dispersions.
Patil MP; Gaikwad NJ
Acta Pharm; 2009 Mar; 59(1):57-65. PubMed ID: 19304558
[TBL] [Abstract][Full Text] [Related]
32. Understanding Dissolution and Crystallization with Imaging: A Surface Point of View.
Novakovic D; Isomäki A; Pleunis B; Fraser-Miller SJ; Peltonen L; Laaksonen T; Strachan CJ
Mol Pharm; 2018 Nov; 15(11):5361-5373. PubMed ID: 30247922
[TBL] [Abstract][Full Text] [Related]
33. Drug-Smectite Clay Amorphous Solid Dispersions Processed by Hot Melt Extrusion.
Nandi U; Mithu MSH; Hurt AP; Trivedi V; Douroumis D
AAPS PharmSciTech; 2020 Oct; 21(7):276. PubMed ID: 33033890
[TBL] [Abstract][Full Text] [Related]
34. Mechanistic investigation of Pluronic based nano-crystalline drug-polymer solid dispersions.
Qian F; Tao J; Desikan S; Hussain M; Smith RL
Pharm Res; 2007 Aug; 24(8):1551-60. PubMed ID: 17380258
[TBL] [Abstract][Full Text] [Related]
35. New binary solid dispersion of indomethacin with surfactant polymer: from physical characterization to in vitro dissolution enhancement.
Sivert A; Bérard V; Andrès C
J Pharm Sci; 2010 Mar; 99(3):1399-413. PubMed ID: 19827098
[TBL] [Abstract][Full Text] [Related]
36. Effect of composition in the development of carbamazepine hot-melt extruded solid dispersions by application of mixture experimental design.
Djuris J; Ioannis N; Ibric S; Djuric Z; Kachrimanis K
J Pharm Pharmacol; 2014 Feb; 66(2):232-43. PubMed ID: 24350884
[TBL] [Abstract][Full Text] [Related]
37. Influence of pH and method of crystallization on the solid physical form of indomethacin.
Dubbini A; Censi R; Martena V; Hoti E; Ricciutelli M; Malaj L; Di Martino P
Int J Pharm; 2014 Oct; 473(1-2):536-44. PubMed ID: 25064728
[TBL] [Abstract][Full Text] [Related]
38. Enhanced solubility of piperine using hydrophilic carrier-based potent solid dispersion systems.
Thenmozhi K; Yoo YJ
Drug Dev Ind Pharm; 2017 Sep; 43(9):1501-1509. PubMed ID: 28425323
[TBL] [Abstract][Full Text] [Related]
39. Novel supercritical carbon dioxide impregnation technique for the production of amorphous solid drug dispersions: a comparison to hot melt extrusion.
Potter C; Tian Y; Walker G; McCoy C; Hornsby P; Donnelly C; Jones DS; Andrews GP
Mol Pharm; 2015 May; 12(5):1377-90. PubMed ID: 25730138
[TBL] [Abstract][Full Text] [Related]
40. Exploring the use of spray congealing to produce solid dispersions with enhanced indomethacin bioavailability: In vitro characterization and in vivo study.
Bertoni S; Albertini B; Ferraro L; Beggiato S; Dalpiaz A; Passerini N
Eur J Pharm Biopharm; 2019 Jun; 139():132-141. PubMed ID: 30910731
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
